Literature DB >> 22196927

Synthesis and hydrolysis studies of novel glyco-functionalized platinum complexes.

Janina Möker1, Joachim Thiem.   

Abstract

Cisplatin and some of its derivatives are among the most active cytostatics for cancer treatment. Unfortunately, application of platinum complexes always indicates side effects, and frequently primary or developed resistance of tumour cells appear. Therefore, development of novel analogues especially with natural ligands is expedited. Glyco-functionalized ligands were obtained via ether synthesis with ω-halo ethers, Finkelstein reaction, with further treatment with malonate and final deprotection followed by preparation of the disodium salts. Subsequent complexation led to novel platinum derivatives, the stabilities of which in aqueous solution media were studied.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22196927     DOI: 10.1016/j.carres.2011.08.024

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

Review 1.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

2.  Protected and De-protected Platinum(IV) Glycoconjugates With GLUT1 and OCT2-Mediated Selective Cancer Targeting: Demonstrated Enhanced Transporter-Mediated Cytotoxic Properties in vitro and in vivo.

Authors:  Jing Ma; Hanfang Liu; Zhuoqing Xi; Jiuzhou Hou; Yingguang Li; Jie Niu; Tong Liu; Shuning Bi; Xin Wang; Chaojie Wang; Jiajia Wang; Songqiang Xie; Peng G Wang
Journal:  Front Chem       Date:  2018-09-21       Impact factor: 5.221

3.  Stereoselective Synthesis of Carbon-Sulfur-Bridged Glycomimetics by Photoinitiated Thiol-Ene Coupling Reactions.

Authors:  Magdolna Csávás; Dániel Eszenyi; Erika Mező; László Lázár; Nóra Debreczeni; Marietta Tóth; László Somsák; Anikó Borbás
Journal:  Int J Mol Sci       Date:  2020-01-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.